A Watch-Type Electrocardiography Is a Reliable Tool for Detecting Paroxysmal Cardiac Arrhythmias
- PMID: 35743404
- PMCID: PMC9224975
- DOI: 10.3390/jcm11123333
A Watch-Type Electrocardiography Is a Reliable Tool for Detecting Paroxysmal Cardiac Arrhythmias
Abstract
Background: A substantial proportion of cardiac arrhythmias are paroxysmal in nature, and 12-lead electrocardiography (ECG) and Holter monitoring often fail to detect paroxysmal arrhythmias. We designed and evaluated a watch-type, electrocardiograph-recording, wearable device (w-ECG) to overcome the limitations of 12-lead ECG and Holter monitoring. Methods: We prospectively enrolled 96 patients with symptoms assumed to be related to cardiac arrhythmias. Electrocardiography recording was performed with both the w-ECG and Holter monitoring. Detection of any arrhythmia was the primary outcome endpoint and was compared between the w-ECG and Holter monitoring. Results: Any arrhythmia was detected in 51 (53.1%) and 27 (28.1%) patients by the w-ECG and Holter monitoring, respectively (odds ratio (OR) = 2.9, p < 0.001). The w-ECG was superior to Holter monitoring for the detection of clinically significant arrhythmias (excluding atrial premature contraction, ventricular premature contraction, and non-sustained atrial tachyarrhythmia) (OR = 2.34, p = 0.018). In 27 (28.1%) patients, cardiac arrhythmias were detected only by the w-ECG, with atrial fibrillation being the most frequent case (13 patients). Based on ECGs recorded by using the w-ECG, 17 patients (17.7%) received therapeutic interventions, including radiofrequency catheter ablation. Conclusions: The w-ECG is capable of recording ECGs of good quality, with a discernable P wave and distinguishable QRS morphology. The ability of the w-ECG to detect cardiac arrhythmias was significantly better than that of Holter monitoring, and a significant proportion of patients received therapeutic intervention based on ECGs recorded by the w-ECG.
Keywords: arrhythmia; electrocardiography; smartwatch; watch-type ECG; wearable device.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Applicability of a Novel Wearable Wireless Electrocardiogram Monitoring Device (Spyder) for Arrhythmia Detection in Patients with Suspected Cardiac Arrhythmias.Cardiol Res Pract. 2021 Nov 26;2021:8496351. doi: 10.1155/2021/8496351. eCollection 2021. Cardiol Res Pract. 2021. PMID: 34868676 Free PMC article.
-
Effectiveness of Implanted Cardiac Rhythm Recorders With Electrocardiographic Monitoring for Detecting Arrhythmias in Pregnant Women With Symptomatic Arrhythmia and/or Structural Heart Disease: A Randomized Clinical Trial.JAMA Cardiol. 2020 Apr 1;5(4):458-463. doi: 10.1001/jamacardio.2019.5963. JAMA Cardiol. 2020. PMID: 32074256 Free PMC article. Clinical Trial.
-
Comparison of Arrhythmia Detection by 24-Hour Holter and 14-Day Continuous Electrocardiography Patch Monitoring.Acta Cardiol Sin. 2020 May;36(3):251-259. doi: 10.6515/ACS.202005_36(3).20190903A. Acta Cardiol Sin. 2020. PMID: 32425440 Free PMC article.
-
Wearable Electrocardiogram Technology: Help or Hindrance to the Modern Doctor?JMIR Cardio. 2025 Feb 10;9:e62719. doi: 10.2196/62719. JMIR Cardio. 2025. PMID: 39931024 Free PMC article. Review.
-
Contemporary wearable and handheld technology for the diagnosis of cardiac arrhythmias in Singapore.Singapore Med J. 2023 Sep 19. doi: 10.4103/singaporemedj.SMJ-2023-048. Online ahead of print. Singapore Med J. 2023. PMID: 37870042 Review.
Cited by
-
Screening and Risk Analysis of Atrial Fibrillation After Radiotherapy for Breast Cancer: Protocol for the Cross-Sectional Cohort Study "Watch Your Heart (WATCH)".JMIR Res Protoc. 2025 Jun 4;14:e67875. doi: 10.2196/67875. JMIR Res Protoc. 2025. PMID: 40466092 Free PMC article.
-
Increased Mortality Associated with Amiodarone Compared to Other Antiarrhythmic Drugs in New-Onset Atrial Fibrillation.J Clin Med. 2025 Feb 11;14(4):1168. doi: 10.3390/jcm14041168. J Clin Med. 2025. PMID: 40004699 Free PMC article.
-
Wearable heart rate variability and atrial fibrillation monitoring to improve clinically relevant endpoints in cardiac surgery-a systematic review.Mhealth. 2023 Dec 12;10:8. doi: 10.21037/mhealth-23-19. eCollection 2024. Mhealth. 2023. PMID: 38323143 Free PMC article. Review.
-
A Patch-Type Electrocardiography Is Superior to Holter Monitoring for Detecting Paroxysmal Cardiac Arrhythmias.J Korean Med Sci. 2025 Jul 21;40(28):e168. doi: 10.3346/jkms.2025.40.e168. J Korean Med Sci. 2025. PMID: 40696526 Free PMC article.
References
-
- Dai H., Zhang Q., Much A.A., Maor E., Segev A., Beinart R., Adawi S., Lu Y., Bragazzi N.L., Wu J. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: Results from the Global Burden of Disease Study 2017. Eur. Heart J. Qual. Care Clin. Outcomes. 2020;7:574–582. doi: 10.1093/ehjqcco/qcaa061. - DOI - PMC - PubMed
-
- Kim Y.G., Han K.-D., Choi J.-I., Choi Y.Y., Choi H.Y., Boo K.Y., Kim D.Y., Lee K.-N., Shim J., Kim J.-S., et al. Non-genetic risk factors for atrial fibrillation are equally important in both young and old age: A nationwide population-based study. Eur. J. Prev. Cardiol. 2020;28:666–676. doi: 10.1177/2047487320915664. - DOI - PubMed
-
- Kim Y.G., Han K.D., Kim D.Y., Choi Y.Y., Choi H.Y., Roh S.Y., Shim J., Kim J.S., Choi J.I., Kim Y.H. Different Influence of Blood Pressure on New-Onset Atrial Fibrillation in Pre- and Postmenopausal Women: A Nationwide Population-Based Study. Hypertension. 2021;77:1500–1509. doi: 10.1161/HYPERTENSIONAHA.120.16513. - DOI - PubMed
-
- Katritsis D.G., Marine J.E., Contreras F.M., Fujii A., Latchamsetty R., Siontis K.C., Katritsis G.D., Zografos T., John R.M., Epstein L.M., et al. Catheter Ablation of Atypical Atrioventricular Nodal Reentrant Tachycardia. Circulation. 2016;134:1655–1663. doi: 10.1161/CIRCULATIONAHA.116.024471. - DOI - PubMed
-
- Dinov B., Fiedler L., Schonbauer R., Bollmann A., Rolf S., Piorkowski C., Hindricks G., Arya A. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: Results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study. Circulation. 2014;129:728–736. doi: 10.1161/CIRCULATIONAHA.113.003063. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources